€5.30
4.95%
Xetra, Fri, Sep 27 2024
ISIN
DE000A3DSV01
Symbol
HIGH
Index

Cantourage Stock price

€5.30
+0.48 9.96% 1M
-2.91 35.44% 6M
-1.88 26.18% YTD
-3.87 42.20% 1Y
-11.00 67.48% 3Y
-11.00 67.48% 5Y
-11.00 67.48% 10Y
Xetra, Closing price Fri, Sep 27 2024
+0.25 4.95%
ISIN
DE000A3DSV01
Symbol
HIGH
Index

Key metrics

Market capitalization €62.96m
Enterprise Value €62.93m
P/E (TTM) P/E ratio 1,629.03
EV/Sales (TTM) EV/Sales 37.91
P/S ratio (TTM) P/S ratio 37.93
P/B ratio (TTM) P/B ratio 1.42
Revenue (TTM) Revenue €1.66m
EBIT (operating result TTM) EBIT €78.00k
EPS (TTM) EPS €0.00
P/E forward 84.17
P/S forward 1.55
EV/Sales forward 1.55
Show more

Is Cantourage a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Cantourage Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Cantourage:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Cantourage:

Buy
100%

Financial data from Cantourage

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '23
+/-
%
1.66 1.66
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 1.60 1.60
-
96%
- Research and Development Expense - -
-
-
0.08 0.08
-
5%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 0.08 0.08
-
5%
Net Profit 0.04 0.04
-
2%

In millions EUR.

Don't miss a Thing! We will send you all news about Cantourage directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cantourage Stock News

EQS
18 days ago
Einstufung von Montega AG zu Cantourage Group SE
EQS
24 days ago
Philip Schetter, CEO von Cantourage, sagt: „Unsere aktuelle Geschäftsentwicklung zeigt deutlich, dass wir im Vorfeld der Teillegalisierung von Cannabis in Deutschland die richtigen Schritte eingeleitet hatten. Neben der Ausweitung unseres Produktangebots für hochwertiges Cannabis aus aller Welt k...
EQS
24 days ago
Cantourage ist ein führendes europäisches Unternehmen für die Herstellung und den Vertrieb von Medizinalpräparaten und Arzneimitteln auf Basis von Cannabis. Das in Berlin ansässige Unternehmen wurde 2019 von den Branchenpionieren Norman Ruchholtz, Dr. Florian Holzapfel und Patrick Hoffmann gegrün...
More Cantourage News

Company Profile

Head office Germany
CEO Philip Schetter
Founded 2019
Website www.cantourage.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today